Firmagon (Generic name: Degarelix Acetate) is a FDA-approved new injectable medication used for the treatment of advanced and hormone-dependent prostate cancer in adult male patients. Firmagon contains the active substance Degarelix that works by suppressing the amount of testosterone in the body to slow the growth of cancer cells. Firmagon is administered as a subcutaneous (SC) injection in abdomen area.
Back to Drug Categories Page